Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

This segment is sponsored by Nerivio.Millions of Americans suffer from migraine, but now, an innovative and drug-free treatment option is making it easier for ...

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

Holding announced that it has received approval of a New Drug Submission, NDS, from the Health Canada’s Pharmaceutical Drugs ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Migraine medications often come with side effects. Learn how to minimize discomfort and find relief while managing migraine.

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper device was effective in treating acute ...

Delivering room-temperature air through the nose to cool the sphenopalatine ganglion taps into a powerful neuromodulatory ...